Village Farms International Takes Top Honors at the 2025 Stevie® Awards - Village Farms Intl ( NASDAQ:VFF )
VANCOUVER, British Columbia, April 28, 2025 ( GLOBE NEWSWIRE ) -- Village Farms International, Inc. ( "Village Farms" or the "Company" ) VFF was named the winner of two Gold Stevie® Awards and one Bronze Stevie® Award in the 23rd Annual American Business Awards®.
Nayax to Showcase End-to-End Payment Ecosystem at The NAMA Show, May 7-9 in Las Vegas - Nayax ( NASDAQ:NYAX )
HERZLIYA, Israel, April 28, 2025 ( GLOBE NEWSWIRE ) -- Nayax Ltd. NYAXNYAX ) , a global commerce enablement payments and loyalty platform designed to help merchants scale their business, will be showcasing its range of solutions at The NAMA Show 2025.
Senti Bio's SENTI-202, a First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results in the Treatment of Patients with Relapsed/Refractory AML
Data presented at the American Association for Cancer Research ( AACR ) Annual Meeting ...
ScottsMiracle-Gro CEO Reports Strong POS Unit Gains During CNBC Mad Money Appearance - Scotts Miracle Gro ( NYSE:SMG )
MARYSVILLE, Ohio, April 28, 2025 ( GLOBE NEWSWIRE ) -- The Scotts Miracle-Gro Company SMG, the world's leading marketer of branded consumer lawn and garden products as well as a leader in indoor and hydroponic growing products, reported that Chairman and CEO Jim Hagedorn announced during an ...
Avacta Therapeutics Presents Preclinical and Translational Data from pre|CISION® Platform Candidates at 2025 AACR Annual Meeting
LONDON and PHILADELPHIA, April 28, 2025 ( GLOBE NEWSWIRE ) -- Avacta Therapeutics AVCT, a life sciences company developing next generation peptide drug conjugates ( PDC ) targeting powerful anti-tumor payloads directly to the tumor, today announced preclinical results from its second pre|CISION® ...
EYLEA HD® ( aflibercept ) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease
Initial real-world data from nearly 40,000 EYLEA HD patients will provide early insights on effectiveness of EYLEA HD in everyday clinical practice ...
Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025 - Ocular Therapeutix ( NASDAQ:OCUL )
BEDFORD, Mass., April 28, 2025 ( GLOBE NEWSWIRE ) -- Ocular Therapeutix, Inc. OCUL "Ocular" ) ) , a biopharmaceutical company committed to redefining the retina experience, today announced that it plans to issue a press release regarding first quarter 2025 financial results on Monday, May 5, 2025 ...
XORTX Announces Grant of European Patent - XORTX Therapeutics ( NASDAQ:XRTX )
CALGARY, Alberta, April 28, 2025 ( GLOBE NEWSWIRE ) -- XORTX Therapeutics Inc. ( "XORTX" or the "Company" ) XRTXXRTXANU ) , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease , is pleased to announce receipt of ...
Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 - Arvinas ( NASDAQ:ARVN )
NEW HAVEN, Conn., April 28, 2025 ( GLOBE NEWSWIRE ) -- Arvinas, Inc. ARVN, a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that management will review first quarter 2025 financial results and provide a corporate ...
G2 Continues to Expand New Surface Gold Discovery and Provides Exploration Update
TORONTO, April 28, 2025 ( GLOBE NEWSWIRE ) -- G2 Goldfields Inc. ( "G2" or the "Company" ) ( TSX: GTWO. OTCQX: GUYGF ) provides further information on the Company's ongoing diamond drilling and exploration initiatives in the greater Oko-Aremu District, Guyana.
